bambuterol
Sign in to saveBambuterol (INN) is a long-acting β adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline. Commercially, the AstraZeneca pharmaceutical company produces and markets bambuterol as Bambec and Oxeol.
Research
197 papers- Rivastigmine-Bambuterol Hybrids as Selective Butyrylcholinesterase Inhibitors.Molecules (Basel, Switzerland) · 2023
- Clinical pharmacokinetics of bambuterol.Clinical pharmacokinetics · 1996
- Mechanism of action of bambuterol: a beta-agonist prodrug with sustained lung affinity.Agents and actions. Supplements · 1991
- [Bambuterol].Ugeskrift for laeger · 1992
- (R)-Bambuterol attenuates DSS-induced chronic colitis by suppressing inflammation, repairing intestinal barrier, and modulating gut microbiota and serum metabolomic profile.European journal of pharmacology · 2025
via PubMed
Article
6 sectionsContents
- Indications
- Contraindications
- Adverse effects
- Interactions
- Synthesis
- References
Bambuterol (INN) is a long-acting β adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline. Commercially, the AstraZeneca pharmaceutical company produces and markets bambuterol as Bambec and Oxeol.
It is not available in the U.S.